"REDUCTION OF GLUTAMATERGIC NEUROTRANSMISSION BY PROLONGED EXPOSURE TO DIELDRIN INVOLVES NMDA RECEPTOR INTERNALIZATION AND METABOTROPIC GLUTAMATE RECEPTOR 5 DOWNREGULATION."
''SEROTONIN 5-HT2C: CHEMICAL NEUROANATOMY IN THE MAMMALIAN BRAIN.''
"REDUCED SIGNAL TRANSDUCTION BY 5-HT4 RECEPTORS AFTER LONG-TERM VENLAFAXINE TREATMENT IN RATS."
''DISTRIBUTION OF OF 5-HT RECEPTORS IN THE CENTRAL NERVOUS SYSTEM.''
"USE OF GENE EXPRESSION OF NEURAL MARKERS IN CULTURED NEURAL CELLS TO IDENTIFY DEVELOPMENTAL NEUROTOXICANTS."
"DOPAMINE D1, D2 AND MU-OPIOID RECEPTORS ARE CO-EXPRESSED WITH ADENYLYL CYCLASE 5 AND PHOSPHODIESTERASE 7B MRNAS IN STRIATAL RAT CELLS."
"UNRAVELING MONOAMINE RECEPTORS INVOLVED IN THE ACTION OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON GLUTAMATERGIC AND SEROTONERGIC TRANSMISSION IN PREFRONTAL CORTEX."
A FUNCTIONAL LEPTIN SYSTEM IS ESSENTIAL FOR SODIUM TUNGSTATE ANTIOBESITY ACTION
EFFECTS OF EARLY VS. LATE INITIATION OF LEVODOPA TREATMENT IN HEMIPARKINSONIAN RATS.
EVIDENCE FOR DISTINCT ANTAGONIST-REVEALED FUNCTIONAL STATES OF 5-HYDROXYTRYPTAMINE(2A) RECEPTOR HOMODIMERS
METHILMERCURY DISRUPTS THE BALANCE BETWEEN PHOSPHORYLATED AND NON-PHOSPHORYLATED COFILIN IN PRIMARY CULTURES OF MICE CEREBELLAR GRANULE CELLS A PROTEOMIC STUDY
LACK OF CB1 RECEPTOR ACTIVITY IMPAIRS SEROTONERGIC NEGATIVE FEEDBACK
NEURONAL IN VITRO MODELS FOR THE ESTIMATION OF ACUTE SYSTEMIC TOXICITY
ROLE OF DIFFERENT MONOAMINE RECEPTORS CONTROLLING MK-801-INDUCED RELEASE OF SEROTONIN AND GLUTAMATE IN THE MEDIAL PREFRONTAL CORTEX: RELEVANCE FOR ANTIPSYCHOTIC ACTION
QUANTITATIVE ANALYSIS OF THE EXPRESSION OF DOPAMINE D-1 AND D-2 RECEPTORS IN PYRAMIDAL AND GABAERGIC NEURONS OF THE RAT PREFRONTAL CORTEX
PYRAMIDAL NEURONS IN RAT PREFRONTAL CORTEX PROJECTING TO VENTRAL TEGMENTAL AREA AND DORSAL RAPHE NUCLEUS EXPRESS 5-HT2A RECEPTORS
PROBUCOL INCREASES GLUTATHIONE PEROXIDASE-1 ACTIVITY AND DISPLAYS LONG-LASTING PROTECTION AGAINST METHYLMERCURY TOXICITY IN CEREBELLAR GRANULE CELLS
PINDOLOL AUGMENTATION ENHANCES RESPONSE OUTCOMES IN FIRST DEPRESSIVE EPISODES
SPATIAL DISTRIBUTION OF PARKINSON'S DISEASE MORTALITY IN SPAIN, 1989-1998, AS A GUIDE FOR FOCUSED AETIOLOGICAL RESEARCH OR HEALTH-CARE INTERVENTION
